New Center Takes Aim at Resistance.
The Institute of Cancer Research in London recently announced the launch of a center that will bring together drug developers and evolutionary biologists to tackle drug resistance. Research at the center will focus on designing better combination strategies for existing cancer therapies based on how tumors evolve, and developing new drugs that target the evolution of cancer.